Find out what Alzheimer’s disease is – learn about its causes, characteristic symptoms, diagnostic methods, and treatment options step by step.
Table of Contents
- What is Alzheimer’s disease? – definition and basic information
- Causes of Alzheimer’s disease – risk factors and etiology
- Most common Alzheimer’s symptoms – how to recognize early signs
- Stages of Alzheimer’s disease – progression and course
- Diagnostics and modern methods for detecting Alzheimer’s
- Treatment and prevention – current therapies and support for patients and caregivers
What is Alzheimer’s disease? – definition and basic information
Alzheimer’s disease is a progressive, neurodegenerative brain disorder and the most common cause of dementia in the elderly. It was first described in 1906 by the German psychiatrist and neurologist Alois Alzheimer, who identified characteristic neuropathological changes in the brain of a patient suffering from a mysterious form of dementia. Alzheimer’s leads to irreversible loss of nerve cells and their connections, disrupting the proper function of brain structures responsible for memory, thinking, speech, orientation, learning abilities, and the performance of daily activities. The loss of neurons and progressive atrophic changes within the brain mean that over time, the disease causes a significant loss of independence in the patient, even leading to complete dependency on caregivers. It is currently estimated that worldwide, 35 to 50 million people suffer from Alzheimer’s disease, and this number is expected to steadily increase in the coming decades, mainly due to aging populations.
Alzheimer’s disease can manifest in both classic and rarer forms. It most commonly occurs in individuals over 65, though early-onset cases may appear as early as the 40s or 50s, usually with a genetic basis. The disease develops gradually – initially, mild, atypical short-term memory difficulties dominate, often mistaken for normal aging. As the disease progresses, other cognitive functions such as speech, reasoning, organizational skills, or judgment become impaired. Neuropathological hallmarks in the brains of people with Alzheimer’s include beta-amyloid deposits forming amyloid plaques and neurofibrillary tangles made of tau protein. Amyloid plaques accumulate in the intercellular spaces, contributing to synaptic dysfunction and neuronal damage, while neurofibrillary tangles disturb the structure and function of neurons from within. As a result, there is gradual degeneration of the cerebral cortex neurons and other brain areas, which manifests in increasing cognitive problems, behavioral changes, and ultimately deep dementia. As the disease advances, physical capabilities also worsen. Alzheimer’s disease is chronic and incurable – there is currently no effective causal treatment, and available therapies are aimed mainly at alleviating symptoms, slowing disease progression, and improving quality of life for patients and their families. Early diagnosis, education of caregivers, and adaptation of the environment to the patient’s needs all play crucial roles. Difficulty in quick recognition is also due to the fact that symptoms can develop for years, progress slowly, and be ignored either by families or the patient until daily functioning is affected. Alzheimer’s disease poses a huge health, social, and organizational challenge for healthcare systems worldwide because of the huge number of cases, the long disease course, and the significant burden on families and society. Current research, conducted intensively worldwide, focuses on understanding the exact mechanisms of this disease and searching for new methods for effective treatment and early diagnosis.
Causes of Alzheimer’s disease – risk factors and etiology
Despite years of research, the precise causes of Alzheimer’s disease are still not fully understood, yet scientists point to a complex combination of genetic, environmental, and lifestyle factors that contribute to its development. The strongest, well-documented risk factor is age – the probability of developing Alzheimer’s increases considerably after age 65, with each subsequent decade bringing several times higher risk. Genetic predispositions also play an important role. Family occurrence suggests a hereditary component, with a special role attributed to certain variants of the APOE (apolipoprotein E) gene, especially the APOE ε4 type. People with this allele have an increased susceptibility, but it does not predetermine the disease – many patients do not have APOE ε4 and some carriers never develop Alzheimer’s. Mutations of other genes (APP, PSEN1, PSEN2), which are rarer, are responsible for early-onset Alzheimer’s cases appearing before the age of 60. However, genetics is only one piece of the puzzle – research has shown that environment and lifestyle are also impactful. Environmental factors increasing risk include chronic stress, insufficient physical activity, diets rich in saturated fats and poor in nutrients, tobacco smoking, and alcohol abuse. Hypertension, type 2 diabetes, obesity, and high cholesterol are comorbid conditions that are also associated with higher probability of Alzheimer’s-type dementia. Studies suggest that low intellectual activity throughout life, lack of mental stimulation, and social isolation can speed up neurodegeneration and increase susceptibility to cognitive disorders. Head injuries are noteworthy, as they may cause microdamage in the brain tissue – people with a history of serious head trauma are statistically more prone to Alzheimer’s.
From a biological point of view, key roles in Alzheimer’s pathogenesis are played by molecular and cellular changes in the brain. The most characteristic are deposits of beta-amyloid in extracellular spaces, leading to so-called senile plaques, and the formation within neurons of neurofibrillary tangles made of hyperphosphorylated tau protein. The presence of these structures disrupts communication between neurons, hinders nutrient transport, and initiates local inflammatory reactions that result in gradual neuron death. This process is promoted by abnormal activation of microglia and disturbed metabolic balance in the brain. Despite intensive research, what exactly initiates these pathological changes remains uncertain – it is suspected that both genetic factors (e.g., mutations causing excessive amyloid production) and chronic inflammation, oxidative stress, or underdevelopment of cerebral blood vessels can trigger them. Modern concepts also highlight the importance of mitochondrial dysfunction, which leads to neuron energy deficits, increased free radicals, and activation of cell apoptosis. Recently, growing attention is paid to the role of the immune system and potential involvement of infectious agents – some studies suggest a possible link between viral or bacterial infections and the intensification of Alzheimer’s pathology. The accumulation and mutual impact of the above factors explain why the course of the disease can be so varied, and why its risk increases with age, but also in the presence of certain chronic diseases and unhealthy lifestyles.
Most common Alzheimer’s symptoms – how to recognize early signs
Recognizing the early symptoms of Alzheimer’s disease is a key challenge for both the patient and their loved ones. The initial signs may seem minor and are often mistaken for typical cognitive changes due to aging. However, subtle differences in memory, orientation, and daily functioning are the first warning signs. The earliest, and most often overlooked, symptom is typically difficulty remembering new information. Loved ones may notice that a person with Alzheimer’s repeatedly asks the same questions, forgets about recent conversations, the locations of objects, or planned appointments. The patient may misplace items, forget how they got to a specific place, or have trouble remembering where they parked the car. At later stages, memory problems extend to personal life events or recognizing familiar faces. In addition to memory issues, significant difficulties with performing daily life activities arise. Previously routine actions such as preparing a meal, managing household finances, or using the phone become problematic. There may be mistakes in completing complex tasks, or the patient may give up on them, citing fatigue or lack of interest. Simultaneously, orientation disturbances become evident – both in time and space. Someone with Alzheimer’s starts to get lost in familiar places, confuses times of day, forgets dates, or seems confused about current events. Over time, there can be inability to recognize people, places, or circumstances, leading to increasing issues with independent functioning.
In addition to the main cognitive disorders, Alzheimer’s disease brings a range of other symptoms that may also indicate its development. Speech disturbances (aphasia) appear as difficulty finding words, naming objects, or understanding speech. Patients may lose track in conversation, repeat themselves, or have trouble communicating in more complex situations. There is often a gradual loss of the ability to write and read. Another characteristic feature is impaired decision-making and reduced judgment (apraxia, agnosia). The patient may make inappropriate decisions, lose track of how to use everyday objects, or fail to recognize dangers, which can be hazardous at home. Daily functioning can be marked by apathy, decreased motivation, and social withdrawal. Patients gradually lose interest in past hobbies, avoid social contacts, and become less willing to participate in group activities. These changes are often worsened by coexisting depressive or anxiety symptoms. Sometimes, mental symptoms such as irritability, agitation, mood swings, or even delusions and hallucinations represent the first sign, especially in those previously prone to affective disorders. In advanced disease stages, serious motor impairments may appear, such as gait disturbances, muscle rigidity, or difficulties swallowing, leading to increasing dependency. Therefore, it is important to observe not only typical cognitive symptoms but also changes in behavior, emotional expression, activity levels, and social relationships. A comprehensive observation of multiple, often subtle and progressive signs, provides the best chance for early diagnosis of Alzheimer’s disease, enabling care and support to be tailored already at an early stage.
Stages of Alzheimer’s disease – progression and course
Alzheimer’s disease is a condition with a gradual, chronic progression – most commonly divided into three main stages: early (mild), moderate, and advanced. Each of these stages is characterized by a different severity of symptoms and degree of loss of cognitive function and independence, with transitions between phases being fluid – there are no clear boundaries or strict time frames. In the initial stage, called prodromal or preclinical, brain changes may develop for years before noticeable symptoms emerge. Already at this point, beta-amyloid accumulates and neurofibrillary tangles form, but daily life is usually not significantly affected. As the disease advances to the mild phase, mild, subtle short-term memory problems, such as forgetting recent events or the names of loved ones, start to appear. Patients may have trouble recalling words, repeat questions, lose things, and find it difficult to plan or organize everyday tasks like cooking or managing household finances. At this stage, relative independence is still possible, although some tasks may require assistance. These symptoms are often perceived as a normal part of aging, which sometimes delays diagnosis. Issues with orientation in new places or accidentally getting lost after leaving home are also early warning signs.
As Alzheimer’s progresses, it enters the moderate phase, where memory and other cognitive problems intensify and clearly interfere with daily life. Patients may find it difficult to maintain continuity of thought, participate in conversations, forget the meaning of words, confuse concepts, or invent their own neologisms. Recognizing familiar places, faces, or even close family members becomes increasingly difficult. Disorientation in time (confusing days, seasons, years), sleep disturbances, and emotional fluctuations, such as sudden outbursts of anger, tearfulness, or anxiety, are common. At this stage, patients already require significant help with daily activities: dressing, hygiene, meal preparation, or medication management. Personality changes, suspicion, and social withdrawal become increasingly pronounced. Some patients may experience delirium, hallucinations, or tendencies to wander aimlessly, which poses a challenge for caregivers. The next stage is the advanced phase, when the ability to live independently disappears completely. Patients lose touch with their surroundings, stop recognizing themselves and others, can no longer communicate verbally, and movement disorders worsen – gait disturbances, muscle rigidity, contractures, swallowing difficulties, and incontinence all appear. There is also a high susceptibility to infections and other health complications that can lead to the patient being bedridden. Care at this stage must be around the clock and focused on meeting basic biological needs and alleviating suffering. The pace at which the disease progresses is individual and depends, among other things, on genetics, general health, social support, and initial intellectual ability. In some cases, disease progression lasts many years; in others, it advances relatively rapidly. Understanding the stages and accompanying characteristic symptoms is crucial for early diagnosis, implementing appropriate therapeutic interventions, and adjusting care and support for patients and families.
Diagnostics and modern methods for detecting Alzheimer’s
Diagnosing Alzheimer’s disease is a complex process, which until recently was mainly based on clinical assessment, medical history, and neuropsychological tests. Initial symptoms, such as memory disturbances, disorientation, or language problems, require the physician’s particular attention to distinguish them from other types of dementias or mild cognitive impairment. Detailed interviews with the patient and their family are key in assessing behavioral changes and the degree of daily independence. Standardized tests such as the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), or the clock drawing test are used to provide objective assessments of cognitive functions, including memory, attention, orientation, language, and planning skills. In addition to cognitive tests, it is important to exclude other causes of dementia, such as depression, vitamin deficiencies, thyroid diseases, infections, or chronic metabolic conditions. For this, routine blood and urine tests are carried out.
Today, thanks to significant technological advances, diagnostic opportunities in Alzheimer’s disease have greatly expanded due to modern neuroimaging and biological biomarkers. Brain imaging studies such as magnetic resonance imaging (MRI) and computed tomography (CT) enable the detection of atrophy of certain brain structures, particularly the hippocampus and temporal cortex, which are characteristic of Alzheimer’s. The most recent advances in positron emission tomography (PET) allow the assessment of beta-amyloid or tau protein accumulation in the brain – the main pathological markers of the disease – long before obvious clinical symptoms develop. PET with special tracers like florbetapir or flortaucipir allows visualization and quantitative assessment of abnormal protein deposits linked to Alzheimer’s. At the same time, biological fluid biomarker diagnostics are growing in significance. Cerebrospinal fluid (CSF) testing enables detection of characteristic Alzheimer’s changes in beta-amyloid (Aβ42), total tau protein, and phosphorylated tau levels, long before clinical symptoms. A breakthrough in recent years are innovative, non-invasive blood tests that can detect biochemical markers of Alzheimer’s at an early stage, such as beta-amyloid or phosphorylated tau fragments in plasma. While this method is still in development, it already shows high sensitivity and specificity, offering hope for easier and more accessible screening in the future. Diagnostics also utilize new artificial intelligence technologies analyzing patients’ speech patterns, facial expressions, or brain activity patterns, enabling the detection of subtle changes imperceptible to clinicians. Machine learning algorithms aid in analyzing imaging or neuropsychological test data, predicting the risk of developing Alzheimer’s even before clinical symptoms are evident. The importance of genetic testing is also increasing, as it identifies high-risk mutations and allows for individualized care and prevention plans. Differential diagnosis remains a challenge, especially when other neurological or psychiatric diseases coexist, which is why a multidisciplinary team – neurologist, psychiatrist, neuropsychologist, and nuclear medicine specialist or radiologist – usually decides jointly, using the full spectrum of available tools. The modern approach increasingly emphasizes early detection, before substantial cognitive loss, because an early diagnosis enables faster implementation of therapy and planning for optimal support for the patient and their family. Emerging technologies, the availability of screening, and interdisciplinary cooperation significantly improve the effectiveness of detecting Alzheimer’s disease, opening new horizons for patients and the healthcare system alike.
Treatment and prevention – current therapies and support for patients and caregivers
Modern treatment of Alzheimer’s disease includes a wide array of strategies focused on alleviating symptoms, slowing disease progression, and improving the quality of life for patients and their families. None of the currently available treatments halt neurodegeneration permanently, but as scientific advances continue, increasingly effective therapies are being developed. Pharmacological treatment is primarily based on two main groups of medications: acetylcholinesterase inhibitors (such as donepezil, rivastigmine, or galantamine) and NMDA receptor antagonists (memantine). Drugs from both groups help to improve cognitive function and minimize symptoms such as memory, orientation, or attention disorders, though their effectiveness is individual and most significant in the early and moderate stages of the disease. Recently, innovative biological therapies such as monoclonal antibodies targeting beta-amyloid (e.g. aducanumab, lecanemab) are playing an increasing role – these may limit the accumulation of harmful brain deposits. While these therapies are pioneering, they require further research and greater accessibility. Symptomatic treatment also includes medications for managing mood disturbances, anxiety, or aggression – the choice depends on the patient’s individual needs and requires regular evaluation of effectiveness and safety. Equally vital is cognitive rehabilitation: specialist memory training, occupational therapy, and exercises stimulating intellectual and social functions. Collaboration with a neuropsychologist, speech therapist, and physiotherapist helps maintain independence longer and delay complications such as falls or muscle atrophy.
An inseparable element of effective management is support for caregivers and families, which play a key role in the daily functioning of people with Alzheimer’s. Education, support groups, and consultations with psychologists and therapists help to understand the course of the disease, acquire caregiving and communication skills, and cope with stress and burnout. Social support includes community services, such as day care centers, respite care, and social interventions. In terms of prevention, modifiable factors are crucial – these are steps to take long before symptoms arise. It is advisable to maintain an active lifestyle: regular physical activity, a healthy Mediterranean or DASH diet (rich in vegetables, fruits, fish, olive oil), maintaining a healthy body weight, and controlling coexisting diseases like hypertension, diabetes, or dyslipidemia. Mental stimulation is also vital – solving crosswords, learning foreign languages, taking part in social life, and continually expanding interests. Protecting the brain is further enhanced by quitting smoking, reducing alcohol, avoiding head injuries, and treating sleep disorders and depression. On a systemic level, efforts should be directed towards improving early diagnosis and ensuring access to modern therapies – requiring cooperation between doctors, psychologists, therapists, and community organizations. Conscious prevention and access to multidimensional care allow people with Alzheimer’s and their families to improve functioning and receive support at every stage of coping with this challenging disease.
Summary
Alzheimer’s disease is a chronic neurodegenerative condition that develops over years and affects millions of people worldwide. Early recognition of initial symptoms and awareness of risk factors can help start the diagnostic and treatment process sooner. Modern diagnostic methods allow for more accurate identification, and therapies – while they cannot cure Alzheimer’s – can significantly improve the quality of life for patients and provide better support for their families. Regular health prevention and attention to mental health are important at every stage of life.
